FREMONT, Calif., June 12 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH - News) today announced the establishment of a Scientific Advisory Board to assist in directing the Company’s product development strategies. Members of the scientific advisory board are distinguished members of academia and industry with experience in diagnostic test development and commercialization.
